The company in question is, AstraZeneca PLC (NYSE:AZN) currently with a stock price of 33.23 (-0.81% today). The market cap for AstraZeneca PLC is 84071.9, and is in the sector Healthcare, and Drug Manufacturers – Major industry. The target price for AstraZeneca PLC is 34.5. Currently AstraZeneca PLC is trading with a P/E of 37.85, and a forward P/E of 14.7. Average volume for AstraZeneca PLC is 6152.45 and so far today it is 3892100.
Performance in the last year for AstraZeneca PLC has been 11.67%. For EPS growth, AstraZeneca PLC has seen a growth of 128.90%, and is looking to grow in the next year to -8.50%. More long term stats show that EPS growth has been -16.70% over the last five years and could be -1.00% for the next five years. AstraZeneca PLC has seen sales growth quarter over quarter at -11.20%, with EPS growth quarter over quarter at -100.40%. The 20-day simple moving average is 7.00%, with the 200-day simple moving average coming to 10.56%.
Since the IPO date for AstraZeneca PLC on the 5/17/1993, AstraZeneca PLC has seen performance year to date to be 2.40%. With AstraZeneca PLC trading at 33.23, the dividend yield is 2.71%, and the EPS is 0.88.
So could AstraZeneca PLC, be undervalued? Well as said before P/E is 37.85. The PEG is *TBA, P/S is 3.49 and the P/B is at 6.21. The P/cash is 18.1, with P/free cash flow at *TBA.
AstraZeneca PLC ability to deal with debt shows that the current ratio is 0.9, and the quick ratio is 0.8. This is with long term debt/equity at 1.22, and total debt/equity at 1.3.
In terms of margins, AstraZeneca PLC has a gross margin of 82.20%, an operating margin of 15.00% and a profit margin of 9.20%.Payout ratio for AstraZeneca PLC is 108.10%. Return on assets come to 3.70% with return on investment coming to 11.50%.
Insider ownership for AstraZeneca PLC, is at 0.50% and institutional ownership comes to 12.20%. Outstanding shares are at 2530. While shares float is 2503.33. The float short is currently 1.15%, and short ratio is 4.67.